INTERNATIONAL PATENT: MIE UNIVERSITY, 国立大学法人三重大学 FILES APPLICATION FOR "METHOD FOR DETERMINING WHETHER PATIENT HAS CEREBRAL AMYLOID ANGIOPATHY, METHOD FOR DETERMINING PRESENCE OR RISK OF SIDE EFFECTS OF THERAPY USING ANTI-AMYLOID Β ANTIBODY AGAINST ALZHEIMER'S DISEASE AND METHOD FOR SELECTING PATIENT FOR THERAPY USING ANTI-AMYLOID Β ANTIBODY AGAINST ALZHEIMER'S DISEASE AND COMPOSITION AND KIT FOR SAID METHODS"

GENEVA, March 25 -- MIE UNIVERSITY (1577, Kurimamachiya-cho, Tsu-shi, Mie5148507), 国立大学法人三重大学 (三重県津市栗真町屋町１５７７) filed a patent application (PCT/JP2024/032389) for "METHOD FOR DETERMINING WHETHER PATIENT HAS CEREBRAL AMYLOID ANGIOPATHY, METHOD FOR DETERMINING PRESENCE OR RISK OF SIDE EFFECTS OF THERAPY USING ANTI-AMYLOID Beta ANTIBODY AGAINST ALZHEIMER'S DISEASE, AND METHOD FOR SELECTING PATIENT FOR THERAPY USING ANTI-AMYLOID Beta ANTIBODY AGAINST ALZHEIMER'S DISEASE, AND COMPOSITION AND KIT FOR SAID METHODS" on Sep 10, 2024. With publication no. WO/2025/057945, the details rel...